Nicolas Theys

Nicolas Theys

Company: NOVADIP Biosciences

Job title: Chief Technology Officer


Strategising the Transition from Autologous to Allogeneic Cell Therapy Platforms 11:30 am

• Evaluating development and manufacturing considerations for converting autologous therapies • Discussing strategies to balance implementing allogeneic products while continuing autologous programs • Comparing regulatory requirements between autologous and allogeneic platformsRead more

day: Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.